Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to evaluate the influence of personality profiles in patients with MOH and to evaluate the effect of a custom-made educational programme as an add-on to standard treatment as compared to standard treatment alone in MOH patients using a randomized controlled trial (RCT) design.


Clinical Trial Description

Worldwide, two percent of the population suffers from medication-overuse headache (MOH), a paradox condition where the headache is caused by overuse of headache medication. Common treatment is withdrawal, but there is no consensus on what constitutes the best treatment. The study consists of a RCT with MOH patients randomized to standard treatment versus standard treatment + a 12-week, 6-session educational programme as add-on. The programme is based on theory of motivational interviewing, and patients can choose between individualized education or education in groups. Primary endpoint: Headache frequency measured by self-reported headache diary on number of days with headache pre-vious month. Secondary endpoints: NEO-FFI-3 personality test, coping strategies, pain intensity, bothersomeness, patient satis-faction and reported medication intake. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02768233
Study type Interventional
Source Hospital of South West Jutland
Contact
Status Completed
Phase N/A
Start date October 15, 2015
Completion date January 2019

See also
  Status Clinical Trial Phase
Completed NCT02903329 - Comparison of Two Detoxification Protocols for Treatment of Medication-overuse Headache N/A
Recruiting NCT05528081 - Longitudinal Study of the Patients With Medication-overuse Headache or Migraine That Completed Baseline MRI
Completed NCT01314768 - Brief Intervention for Medication Overuse Headache N/A